SingleApplication FIT Moderately Sensitive Specific for CRC

Single-Application FIT Moderately Sensitive, Specific for CRC

14:00 EST 25 Feb 2019 | Drugs.com

MONDAY, Feb. 25, 2019 -- Single-application fecal immunochemical tests (FITs) have moderate-to-high sensitivity and specificity for colorectal cancer (CRC), according to a review published online Feb. 26 in the Annals of Internal Medicine. Thomas F....

Original Article: Single-Application FIT Moderately Sensitive, Specific for CRC

More From BioPortfolio on "Single-Application FIT Moderately Sensitive, Specific for CRC"